| Financial Year |
March 31 2023 |
| Monetary Funds |
1,744,325,266.60 |
| Held-for-trading Financial Assets |
702,443,287.68 |
| Notes Receivable |
592,373,139.14 |
| Accounts Receivable |
933,853,693.69 |
| Advances to Suppliers |
54,880,993.38 |
| Other Receivables |
55,842,317.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
556,003,732.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
49,619,182.45 |
| Total Current Assets |
5,036,554,055.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
89,922,568.03 |
| Investment Properties |
-- |
| Fixed Assetes |
291,830,537.20 |
| Under-construction Projects |
1,095,755,464.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
123,865,391.93 |
| R&D expenses |
153,206,188.55 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,415,356.34 |
| Deferred Income Tax Assets |
186,059,404.03 |
| Other Non-Current Assets |
8,707,417.28 |
| Sub-Total of Non-Current Assets |
2,028,620,379.37 |
| Total Assets |
7,065,174,434.65 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
275,205,098.82 |
| Accounts Payable |
1,034,832,197.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,833,950.58 |
| Taxes Payable |
41,484,727.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,855,626.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
28,521,413.16 |
| Other Current Liabilities |
17,824,687.87 |
| Sub-Total of Current Liabilities |
1,751,869,432.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
23,940,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
366,493.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
109,211,563.05 |
| Total Liabilities |
1,861,080,995.65 |
| Paid-In Capital(Or Share Stock) |
845,876,603.00 |
| Capital Surplus |
2,598,470,672.75 |
| Surplus Reserve |
65,682,807.89 |
| LESS:Treasury Stock |
251,240.00 |
| Undistributed Profits |
1,687,040,365.56 |
| Minority Stockholder's Interest |
5,574,541.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,198,518,897.26 |
| Owner's Equity（Stockholder's Equity） |
5,204,093,439.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,065,174,434.65 |
